Allon Therapeutics, Inc. reported earnings results for the year ended December 31, 2012. For the year, the company reported a net loss of $14,916,297 or $0.12 per share compared to a net loss of $12,774,995 or $0.15 per share for the year ended December 31, 2011, representing an increase in net loss of $2,141,302.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | +9,900.00% | -.--% | +9,900.00% |
1st Jan change | Capi. | |
---|---|---|
+9,900.00% | 14.11K | |
+29.03% | 48.16B | |
-0.10% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+11.48% | 25.59B | |
-22.74% | 18.96B | |
+9.06% | 12.92B | |
+30.01% | 12.03B | |
-1.51% | 11.77B |
- Stock Market
- Equities
- NPCUF Stock
- News Allon Therapeutics Inc.
- Allon Therapeutics, Inc. Reports Earnings Results for the Year Ended December 31, 2012